NCT04075253 is a NA clinical trial of VO2 peak testing in Tachycardia, Ventricular, sponsored by St. Olavs Hospital.

Who is sponsoring NCT04075253?

NCT04075253 is sponsored by St. Olavs Hospital.

What drugs are being tested in NCT04075253?

Interventions in NCT04075253: VO2 peak testing.

What condition does NCT04075253 study?

NCT04075253 studies Tachycardia, Ventricular, Defibrillators, Implantable.

Is NCT04075253 still recruiting?

NCT04075253 is currently completed. Last updated 26 April 2023.

Last reviewed 2023-04-26 · How we verify

NCT04075253

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acute Effect of One Single Bout of High Intensity Exercise on the Tendency for Ventricular Arrhythmia

Completed NA Last updated 26 April 2023

What this trial tests

NA trial testing VO2 peak testing in Tachycardia, Ventricular in 55 participants. Completed in 2 September 2022.

Timeline

2 September 2019

Primary endpoint
2 September 2022

2 September 2022

Quick facts

Lead sponsor	St. Olavs Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	55
Start date	2 September 2019
Primary completion	2 September 2022
Estimated completion	2 September 2022
Sites	1 location across Norway

Drugs / interventions tested

VO2 peak testing

Conditions studied

Tachycardia, Ventricular — all drugs for Tachycardia, Ventricular →
Defibrillators, Implantable — all drugs for Defibrillators, Implantable →

Sponsor

St. Olavs Hospital

Who can join

18 and older, any sex, with Tachycardia, Ventricular or Defibrillators, Implantable. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate the acute effect of one single bout of high intensity exercise on the tendency for ventricular arrhythmia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Tachycardia, Ventricular

Currently open trials in the same condition.

NCT04798768 — Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing · NA · active not recruiting

Other St. Olavs Hospital trials

Trials by the same sponsor.

NCT07331766 — Collaboratory Treatment Pathway for Chronic Pain Patients. · NA · enrolling by invitation
NCT07305025 — Pelvic Pain Electro-Acupuncture · NA · not yet recruiting
NCT07245264 — Adjuvant Tranexamic Acid (TXA) Versus Surgery Alone for Adult Patients With Chronic Subdural Hematoma (CSDH) · Phase 2, PHASE3 · recruiting
NCT07180433 — Piloting 18F-FAPI PET/MRI for Applications in Breast Cancer · NA · not yet recruiting
NCT06854861 — Premixed Glucagon/Insulin Solution for Faster Insulin Absorption in Type 1 Diabetes · Phase 1, PHASE2 · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04075253 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by St. Olavs Hospital
Last refreshed: 26 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04075253.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing